Vanessa N Raabe (Vanessa Raabe)

Years Active: 2020-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Nadine G Rouphael, Allison Beck, Amy E Kirby, Pengbo Liu, Muktha S Natrajan, Lilin Lai, Varun Phadke, Juton Winston, Vanessa N Raabe, Matthew H Collins, Tigisty Girmay, Alicarmen Alvarez, Nour Beydoun, Vinit Karmali, Joanne Altieri-Rivera, Lisa C Lindesmith, Larry J Anderson, Yuke Wang, Jill El-Khorazaty, Carey Petrie, Ralph S Baric, Shahida Baqar, Christine L Moe, Mark J Mulligan
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum. The Journal of infectious diseases 226 (10) (2022)
Jennifer Lighter, Vanessa N Raabe
Azithromycin Should Not Be Used to Treat COVID-19. Open forum infectious diseases 7 (6) (2020)
Daniel L Barber, Ragini R Kudchadkar, Steven P Fling, Tracey A Day, Julie A Vergara, David Ashkin, Jonathan H Cheng, Lisa M Lundgren, Vanessa N Raabe, Colleen S Kraft, Jorge J Nieva, Martin A Cheever, Paul T Nghiem, Elad Sharon
Tuberculosis following PD-1 blockade for cancer immunotherapy. Science translational medicine 11 (475) (2020)
Robert J Ulrich, Andrea B Troxel, Ellie Carmody, Jaishvi Eapen, Martin Bäcker, Jack A DeHovitz, Prithiv J Prasad, Yi Li, Camila Delgado, Morris Jrada, Gabriel A Robbins, Brooklyn Henderson, Alexander Hrycko, Dinuli Delpachitra, Vanessa N Raabe, Jonathan S Austrian, Yanina Dubrovskaya, Mark J Mulligan
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients. Open forum infectious diseases 7 (10) (2020)

Vanessa N Raabe.css-eqlu8i{font-size:small;padding-left:4px;} (Vanessa Raabe)